Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latuda for Mania in Children and Adolescents
NCT01932541Phase 4Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lurasidone in bipolar I disorder, Bipolar II disorder (BP-II), bipolar spectrum disorder (BSD), sponsored by Massachusetts General Hospital. Planned start Jan 2017; status: withdrawn.
02
Drugs
lurasidone
03
Conditions
bipolar I disorderBipolar II disorder (BP-II)bipolar spectrum disorder (BSD)
Beyond the preview
Go deeper on NCT01932541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01932541.